These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28069485)

  • 61. A critical appraisal of the process of regulatory implementation of novel in vivo and in vitro methods for chemical hazard and risk assessment.
    Piersma AH; Ezendam J; Luijten M; Muller JJ; Rorije E; van der Ven LT; van Benthem J
    Crit Rev Toxicol; 2014 Nov; 44(10):876-94. PubMed ID: 25058877
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The ChemScreen project to design a pragmatic alternative approach to predict reproductive toxicity of chemicals.
    van der Burg B; Wedebye EB; Dietrich DR; Jaworska J; Mangelsdorf I; Paune E; Schwarz M; Piersma AH; Kroese ED
    Reprod Toxicol; 2015 Aug; 55():114-23. PubMed ID: 25656794
    [TBL] [Abstract][Full Text] [Related]  

  • 63. From in vivo to in vitro: The medical device testing paradigm shift.
    Kerecman Myers D; Goldberg AM; Poth A; Wolf MF; Carraway J; McKim J; Coleman KP; Hutchinson R; Brown R; Krug HF; Bahinski A; Hartung T
    ALTEX; 2017; 34(4):479-500. PubMed ID: 28539002
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Validation of Alternative In Vitro Methods to Animal Testing: Concepts, Challenges, Processes and Tools.
    Griesinger C; Desprez B; Coecke S; Casey W; Zuang V
    Adv Exp Med Biol; 2016; 856():65-132. PubMed ID: 27671720
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Advances in acute toxicity testing: strengths, weaknesses and regulatory acceptance.
    Erhirhie EO; Ihekwereme CP; Ilodigwe EE
    Interdiscip Toxicol; 2018 May; 11(1):5-12. PubMed ID: 30181707
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Adverse outcome pathways during early fish development: a conceptual framework for identification of chemical screening and prioritization strategies.
    Volz DC; Belanger S; Embry M; Padilla S; Sanderson H; Schirmer K; Scholz S; Villeneuve D
    Toxicol Sci; 2011 Oct; 123(2):349-58. PubMed ID: 21750347
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Animals and the 3Rs in toxicology research and testing: The way forward.
    Stokes WS
    Hum Exp Toxicol; 2015 Dec; 34(12):1297-303. PubMed ID: 26614819
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Nonanimal Models for Acute Toxicity Evaluations: Applying Data-Driven Profiling and Read-Across.
    Russo DP; Strickland J; Karmaus AL; Wang W; Shende S; Hartung T; Aleksunes LM; Zhu H
    Environ Health Perspect; 2019 Apr; 127(4):47001. PubMed ID: 30933541
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Implementation of the Three Rs in Regulatory Toxicity and Biosafety Assessment: The Indian Perspective.
    Pant AB
    Altern Lab Anim; 2020; 48(5-6):234-251. PubMed ID: 33523713
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Economic benefits of using adaptive predictive models of reproductive toxicity in the context of a tiered testing program.
    Martin MT; Knudsen TB; Judson RS; Kavlock RJ; Dix DJ
    Syst Biol Reprod Med; 2012 Feb; 58(1):3-9. PubMed ID: 22239076
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An alternative approach for the safety evaluation of new and existing chemicals, an exercise in integrated testing.
    Gubbels-van Hal WM; Blaauboer BJ; Barentsen HM; Hoitink MA; Meerts IA; van der Hoeven JC
    Regul Toxicol Pharmacol; 2005 Aug; 42(3):284-95. PubMed ID: 15979772
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Bridging the gap between regulatory acceptance and industry use of non-animal methods.
    Clippinger AJ; Hill E; Curren R; Bishop P
    ALTEX; 2016; 33(4):453-458. PubMed ID: 27254273
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Alternatives to animal experimentation: the regulatory background.
    Garthoff B
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):388-92. PubMed ID: 15982684
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prospects for reducing and refining the use of dogs in the regulatory toxicity testing of pharmaceuticals.
    Broadhead CL; Betton G; Combes R; Damment S; Everett D; Garner C; Godsafe Z; Healing G; Heywood R; Jennings M; Lumley C; Oliver G; Smith D; Straughan D; Topham J; Wallis R; Wilson S; Buckley P
    Hum Exp Toxicol; 2000 Aug; 19(8):440-7. PubMed ID: 11125714
    [TBL] [Abstract][Full Text] [Related]  

  • 75. An overview of structure-activity relationships as an alternative to testing in animals for carcinogenicity, mutagenicity, dermal and eye irritation, and acute oral toxicity.
    Enslein K
    Toxicol Ind Health; 1988 Dec; 4(4):479-98. PubMed ID: 3188045
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Alternative Testing Strategies for Nanomaterials: State of the Science and Considerations for Risk Analysis.
    Shatkin JA; Ong KJ
    Risk Anal; 2016 Aug; 36(8):1564-80. PubMed ID: 27273523
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The current status of exposure-driven approaches for chemical safety assessment: A cross-sector perspective.
    Sewell F; Aggarwal M; Bachler G; Broadmeadow A; Gellatly N; Moore E; Robinson S; Rooseboom M; Stevens A; Terry C; Burden N
    Toxicology; 2017 Aug; 389():109-117. PubMed ID: 28774667
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Promoting the 3Rs to enhance the OECD fish toxicity testing framework.
    Hutchinson TH; Wheeler JR; Gourmelon A; Burden N
    Regul Toxicol Pharmacol; 2016 Apr; 76():231-3. PubMed ID: 26873775
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The value of selected in vitro and in silico methods to predict acute oral toxicity in a regulatory context: results from the European Project ACuteTox.
    Prieto P; Kinsner-Ovaskainen A; Stanzel S; Albella B; Artursson P; Campillo N; Cecchelli R; Cerrato L; Díaz L; Di Consiglio E; Guerra A; Gombau L; Herrera G; Honegger P; Landry C; O'Connor JE; Páez JA; Quintas G; Svensson R; Turco L; Zurich MG; Zurbano MJ; Kopp-Schneider A
    Toxicol In Vitro; 2013 Jun; 27(4):1357-76. PubMed ID: 22922246
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Regulatory landscape of alternatives to animal testing in food safety evaluations with a focus on the western world.
    Reddy N; Lynch B; Gujral J; Karnik K
    Regul Toxicol Pharmacol; 2023 Sep; 143():105470. PubMed ID: 37591329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.